Many cytokines, growth factors and their receptors can activate anti‐apoptotic and pro‐survival signalling pathways, including the JAK/STAT and ERK1/2 pathways, which can alter the molecular and biological function of AML cells. The gene discussed is SOAT1; the disease is acute myeloid leukemia.